D. Hadler
Impact in
- Pharmacology top 10%
- Cholinesterase and Neurodegenerative Diseases
Papers in
-
- Coenzyme Q10 studies and effects 5
- Mitochondrial Function and Pathology 4
- Genetics 5
- Hemoglobinopathies and Related Disorders 5
- Co-authors
- Hans Gutzmann (3 shared papers)Stefan G. Hofmann (2 shared papers)S. Kanowski (1 shared paper)Ralf Ihl (1 shared paper)Michael Linden (1 shared paper)Klaus-Peter Kühl (1 shared paper)Michael A. Rapp (1 shared paper)W.M. Herrmann (1 shared paper)
- Journals
- Blood (4 papers)Human Psychopharmacology Clinical and Experimental (2 papers)International Psychogeriatrics (1 paper)Neuropsychobiology (1 paper)Lung Cancer (1 paper)
- Partner nations
- GermanySwitzerlandOman
In The Last Decade
D. Hadler
19 papers receiving 541 citations
Peers
Comparison fields: 5 of 73
- Biological Psychiatry 19
- Pharmacology 100
- Psychiatry and Mental health 83
- Physiology 139
- Biochemistry 38
Countries citing papers authored by D. Hadler
This map shows the geographic impact of D. Hadler's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D. Hadler with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D. Hadler more than expected).
Fields of papers citing papers by D. Hadler
This network shows the impact of papers produced by D. Hadler. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D. Hadler. The network helps show where D. Hadler may publish in the future.
Co-authors
The 25 scholars most cited alongside D. Hadler, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1998 | 126 | |
| 2 | 1997 | 110 | |
| 3 | 2008 | 64 | |
| 4 | 2002 | 60 | |
| 5 | 1997 | 55 | |
| 6 | 2013 | 38 | |
| 7 | Protocols to demonstrate slowing of Alzheimer disease progression. Position paper from the International Working Group on Harmonization of Dementia Drug Guidelines. The Disease Progression Sub-Group. | 1997 | 28 |
| 8 | 1987 | 19 | |
| 9 | 1996 | 18 | |
| 10 | 1996 | 8 | |
| 11 | 2007 | 7 | |
| 12 | 2006 | 5 | |
| 13 | 2005 | 5 | |
| 14 | 1985 | 4 | |
| 15 | Dose-effect relationship of idebenone in an experimental cerebral deficit model. Pilot study in healthy young volunteers with piracetam as reference drug. | 1998 | 3 |
| 16 | 2005 | 2 | |
| 17 | 2014 | 2 | |
| 18 | 2006 | 1 | |
| 19 | 2000 | 1 |
About D. Hadler
D. Hadler is a scholar working on Molecular Biology, Genetics, Pediatrics, Perinatology and Child Health, Hematology and Pharmacology, having authored 19 papers that have together received 556 indexed citations. Recurring topics across this work include Coenzyme Q10 studies and effects (5 papers), Hemoglobinopathies and Related Disorders (5 papers), Mitochondrial Function and Pathology (4 papers), Iron Metabolism and Disorders (3 papers), Pharmacological Effects and Toxicity Studies (3 papers), Cholinesterase and Neurodegenerative Diseases (2 papers), Heart Failure Treatment and Management (2 papers) and Health Systems, Economic Evaluations, Quality of Life (2 papers). The work is most often cited by research in Biological Psychiatry (19 citations), Pharmacology (100 citations), Psychiatry and Mental health (83 citations), Physiology (139 citations) and Biochemistry (38 citations). D. Hadler has collaborated with scholars based in Germany, Switzerland and Oman. Frequent co-authors include Hans Gutzmann, Stefan G. Hofmann, S. Kanowski, Ralf Ihl, Michael Linden, Klaus-Peter Kühl, Michael A. Rapp, W.M. Herrmann, Joachim von Pawel and Qiang Wang. Their work appears in journals such as Blood, Human Psychopharmacology Clinical and Experimental, International Psychogeriatrics, Neuropsychobiology and Lung Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.